VIPpharma ApS: Financial statements 2020
CVR: 38744763
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
VIPpharma ApS (CVR 38744763) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,150,975 and a net result of DKK 715,678 compared with DKK -172,533 the year before. That is an increase of 92.1% compared with the year before. Equity in the 2020 report amounted to DKK 3,691,607. The solvency ratio was 83.4%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,150,975
- Profit/Loss
- DKK 715,678
- Equity
- DKK 3,691,607
- Total Assets
- DKK 4,426,080
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 2.2 mio. | 716 t. | 3.7 mio. | 2 |
| 2019 | - | 1.1 mio. | -173 t. | 3.1 mio. | 2 |
| 2018 | - | 1.5 mio. | 228 t. | 3.4 mio. | - |
| 2017 | - | 1.2 mio. | 760 | 3.2 mio. | - |
Official annual report
How creditworthy is VIPpharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 22, 2020, VIPinvest ApS is registered as an owner of VIPpharma ApS with an ownership share of 100%.
VIPpharma ApS has published its annual report for 2019. Gross profit came to DKK 1,119,937, and the net result was DKK -172,533.
About VIPpharma ApS
VIPpharma ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Public relations og kommunikation. The management consists of Vibeke Wærens. The company is owned by VIPinvest ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 2,432,365 and a net result of DKK 674,851 compared with DKK 1,191,483 the year before. Equity in the 2025 report amounted to DKK 1,263,395.